Cargando…

Novel Approach for Clinical Validation of the cobas KRAS Mutation Test in Advanced Colorectal Cancer

AIM: Our objective was to assess the performance of the cobas test versus comparators for KRAS mutation status and predicting clinical response to anti-epidermal growth factor receptor (EGFR) therapy in patients with metastatic colorectal cancer (mCRC). METHODS: mCRC samples from 398 patients from R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharma, Abha, Zhang, Guili, Aslam, Shagufta, Yu, Karen, Chee, Melody, Palma, John F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879158/ https://www.ncbi.nlm.nih.gov/pubmed/26984642 http://dx.doi.org/10.1007/s40291-016-0193-4

Ejemplares similares

Multiplex testing for Factor II and Factor V mutations in thrombophilia: technical verification and clinical validation of the cobas® Factor II and Factor V test
por: Longshore, John W., et al.
Publicado: (2018)

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening
por: Saville, Marion, et al.
Publicado: (2019)

Multisite Performance Evaluation of the cobas 5800 System and Comparison to the cobas 6800/8800 Systems for Quantitative Measurement of HBV, HCV, and HIV-1 Viral Load
por: Tschäpe, Jakob, et al.
Publicado: (2022)

Equivalent Performance of the Cobas(®) Cdiff Test for Use on the Cobas(®) Liat(®) System and the Cobas(®) 4800 System
por: Garg, Sachin K, et al.
Publicado: (2017)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
por: Vessies, D. C. L., et al.
Publicado: (2020)

Diagnosis and Monitoring of Hepatitis B Virus Infection Using the Cobas(®) HBV Test for Use on the Cobas(®) 4800 System
por: Ortonne, Valérie, et al.
Publicado: (2021)

Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations
por: Murakami, Shuji, et al.
Publicado: (2022)

Association between KRAS mutation and lung metastasis in advanced colorectal cancer
por: Pereira, A A L, et al.
Publicado: (2015)

KRAS Mutation Status in Bulgarian Patients with Advanced and Metastatic Colorectal Cancer
por: Radanova, Maria, et al.
Publicado: (2023)

Cobá : estrategias adaptativas de tres familias mayas /
por: Daltabuit Godas, Magalí
Publicado: (1988)

HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
por: Soulières, D., et al.
Publicado: (2010)

An in-house real-time polymerase chain reaction: standardisation and comparison with the Cobas Amplicor HBV monitor and Cobas AmpliPrep/Cobas TaqMan HBV tests for the quantification of hepatitis B virus DNA
por: Santos, Ana Paula de Torres, et al.
Publicado: (2016)

KRAS-associated microRNAs in colorectal cancer
por: Ibrahim, Hamizah, et al.
Publicado: (2020)

KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009)

Impact of KRAS Mutations on Management of Colorectal Carcinoma
por: Sullivan, Kevin M., et al.
Publicado: (2011)

KRAS mutations in patients with colorectal cancer in Libya
por: Abudabous, Asma, et al.
Publicado: (2021)

The Therapeutic Landscape for KRAS-Mutated Colorectal Cancers
por: Tria, Simon Manuel, et al.
Publicado: (2023)

Correction: HPV Testing by cobas HPV Test in a Population from Catalonia
por: Lloveras, Belén, et al.
Publicado: (2013)

Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages
por: Li, Wenbin, et al.
Publicado: (2015)

Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer?
por: Kim, Seung Tae, et al.
Publicado: (2015)

System performance evaluation of the cobas t 711 and cobas t 511 coagulation analyzers in routine laboratory settings
por: Kitchen, Steve, et al.
Publicado: (2020)

Reliability of KRAS mutation testing in metastatic colorectal cancer patients across five laboratories
por: Feigelson, Heather Spencer, et al.
Publicado: (2012)

Comparing the cobas Influenza A/B Nucleic acid test for use on the cobas Liat System (Liat) with rapid antigen tests for clinical management of Japanese patients at the point of care
por: Mikamo, Hiroshige, et al.
Publicado: (2022)

Trichomonas vaginalis Detection in Female Specimens with cobas(®) TV/MG for use on the cobas(®) 6800/8800 Systems
por: Marlowe, Elizabeth M., et al.
Publicado: (2019)

KRAS mutational analysis for colorectal cancer: Application: Pharmacogenomic
por: Wang, Grace, et al.
Publicado: (2010)

Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
por: Arrington, Amanda K., et al.
Publicado: (2012)

Novel KRAS Gene Mutations in Sporadic Colorectal Cancer
por: Naser, Walid M., et al.
Publicado: (2014)

IMPACT OF KRAS MUTATIONS IN CLINICAL FEATURES IN COLORECTAL CANCER
por: ZANATTO, Renato Morato, et al.
Publicado: (2020)

Prognostic Value of KRAS Mutations in Colorectal Cancer Patients
por: Koulouridi, Asimina, et al.
Publicado: (2022)

Targeting KRAS(G12C)-Mutated Advanced Colorectal Cancer: Research and Clinical Developments
por: Ji, Jingran, et al.
Publicado: (2022)

A rational two-step approach to KRAS mutation testing in colorectal cancer using high resolution melting analysis and pyrosequencing
por: Mack, Elisabeth, et al.
Publicado: (2016)

Personalized treatment for advanced colorectal cancer: KRAS and beyond
por: Patel, Gargi Surendra, et al.
Publicado: (2013)

Assessment of the Cobas Bio centrifugal analyser
por: Bais, Renze, et al.
Publicado: (1982)

KRAS Mutations Testing in Colorectal Carcinoma Patients in Italy: From Guidelines to External Quality Assessment
por: Normanno, Nicola, et al.
Publicado: (2011)

Evaluation of the Performance of the Cobas CT/NG Test for Use on the Cobas 6800/8800 Systems for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Male and Female Urogenital Samples
por: Van Der Pol, Barbara, et al.
Publicado: (2019)

Cobas Ampliprep/Cobas TaqMan HIV-1 v2.0 Assay: Consequences at the Cohort Level
por: Taylor, Ninon, et al.
Publicado: (2013)

Coba, Quintana Roo : análisis de dos unidades habitacionales mayas
Publicado: (1987)

Clinical-Pathological Correlation of KRAS Mutation Status in Metastatic Colorectal Adenocarcinoma
por: Ribeiro, Karen Bento, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_62io7afciaqm500uu7vr4u537c